Search Results - Anik R. Patel
- Showing 1 - 6 results of 6
-
1
A Cost-Effectiveness Analysis of Diffuse Large B-Cell Lymphoma Treatment Pathways in the United States by Anik R. Patel, Bradley Kievit, Ken Hasegawa, Markqayne Ray, Rishika Sharma, Sarahmaria Hofmann, Rob Blissett, Frederick L. Locke
Published in MDM Policy & Practice (2025-06-01)Get full text
Article -
2
Cost-effectiveness of treating relapsed or refractory 3L+ follicular lymphoma with axicabtagene ciloleucel vs mosunetuzumab in the United States by Olalekan O. Oluwole, Markqayne D. Ray, Richard M. Zur, Cheryl P. Ferrufino, Brett Doble, Anik R. Patel, S. Pinar Bilir
Published in Frontiers in Immunology (2024-05-01)Get full text
Article -
3
Evaluating Alternative Designs of a Multilevel HIV Intervention in Maharashtra, India: The Impact of Stakeholder Constraints by Anik R. Patel, Kelly V. Ruggles, Kimberly Nucifora, Qinlian Zhou, Stephen Schensul, Jean Schensul, Kendall Bryant, R. Scott Braithwaite
Published in MDM Policy & Practice (2018-10-01)Get full text
Article -
4
Betting on the fastest horse: Using computer simulation to design a combination HIV intervention for future projects in Maharashtra, India. by Kelly V Ruggles, Anik R Patel, Stephen Schensul, Jean Schensul, Kimberly Nucifora, Qinlian Zhou, Kendall Bryant, R Scott Braithwaite
Published in PLoS ONE (2017-01-01)Get full text
Article -
5
-
6
Treatment patterns and outcomes in relapsed/refractory follicular lymphoma: results from the international SCHOLAR-5 study by Paola Ghione, M Lia Palomba, Hervé Ghesquieres, Sabela Bobillo, Anik R Patel, Myrna Nahas, Steve Kanters, Kevin Deighton, Anthony Hatswell, Long Ma, Eve H. Limbrick-Oldfield, Julia Thornton Snider, Sally W. Wade, Maria Teresa Riberio, John Radford, Sara Beygi, John Gribben
Published in Haematologica (2022-10-01)Get full text
Article
